N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide

C24H28N8O2S — CID 126511342

IUPACN-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide
SMILESCN1CCN(c2nc3cc(N4CCCCC4)c(NC(=O)c4csc(-c5ccn[nH]5)n4)cc3o2)CC1
InChIInChI=1S/C24H28N8O2S/c1-30-9-11-32(12-10-30)24-28-18-13-20(31-7-3-2-4-8-31)17(14-21(18)34-24)26-22(33)19-15-35-23(27-19)16-5-6-25-29-16/h5-6,13-15H,2-4,7-12H2,1H3,(H,25,29)(H,26,33)
InChIKeyHEXQPQPPRIRALE-UHFFFAOYSA-N
MW492.61 g/mol
LogP3.67
Rot. Bonds5

About N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide

N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide (PubChem CID 126511342) has the molecular formula C24H28N8O2S and a molecular weight of 492.61 g/mol. Its IUPAC name is N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide.

Molecular Properties

Compound NameN-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide
PubChem CID126511342
Molecular FormulaC24H28N8O2S
Molecular Weight492.61 g/mol
Exact Mass492.21
IUPAC NameN-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide
SMILESCN1CCN(c2nc3cc(N4CCCCC4)c(NC(=O)c4csc(-c5ccn[nH]5)n4)cc3o2)CC1
InChIInChI=1S/C24H28N8O2S/c1-30-9-11-32(12-10-30)24-28-18-13-20(31-7-3-2-4-8-31)17(14-21(18)34-24)26-22(33)19-15-35-23(27-19)16-5-6-25-29-16/h5-6,13-15H,2-4,7-12H2,1H3,(H,25,29)(H,26,33)
InChIKeyHEXQPQPPRIRALE-UHFFFAOYSA-N
XLogP3.67
TPSA106.42 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500492.61
LogP ≤ 53.67
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?
The IUPAC name of N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide (CID 126511342) is N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide.
What is the SMILES notation for N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?
The canonical SMILES for N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide is CN1CCN(c2nc3cc(N4CCCCC4)c(NC(=O)c4csc(-c5ccn[nH]5)n4)cc3o2)CC1.
What is the InChIKey of N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?
The InChIKey is HEXQPQPPRIRALE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H28N8O2S/c1-30-9-11-32(12-10-30)24-28-18-13-20(31-7-3-2-4-8-31)17(14-21(18)34-24)26-22(33)19-15-35-23(27-19)16-5-6-25-29-16/h5-6,13-15H,2-4,7-12H2,1H3,(H,25,29)(H,26,33).
What are the key properties of N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide?
N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide has a molecular weight of 492.61 g/mol, XLogP of 3.67, 5 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-methylpiperazin-1-yl)-5-piperidin-1-yl-1,3-benzoxazol-6-yl]-2-(1H-pyrazol-5-yl)-1,3-thiazole-4-carboxamide is sourced from PubChem (CID 126511342), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).